Anteris Technologies Global (NASDAQ:AVR) releases earnings results, misses estimates by $0.09 EPS. August 11, 2026 Key points. * Anteris Technologies Global missed quarterly expectations: The company reported an EPS loss of $0.30, $0.09 worse than consensus, while revenue of $1.01 million fell short of the $1.50 million estimate. * Shares traded around $9.17, with the stock up from its 12-month low of $3.17 but below its high of $11.06. Analysts maintain a "Moderate Buy" consensus and a $16.00 target price, despite one sell rating. * Insider selling remains notable: Major shareholder L1 Capital sold 174,721 shares for about $1.42 million, while insiders have sold approximately 2.37 million shares worth $19.39 million over the past three months. * MarketBeat previews top five stocks to own in September. Anteris Technologies Global (NASDAQ:AVR - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.09), FiscalAI reports. The business had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.50 million. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. Anteris Technologies Global price performance. AVR traded up $0.21 during trading on Tuesday, hitting $9.17. The company's stock had a trading volume of 1,096,833 shares, compared to its average volume of 1,175,484. The stock has a market cap of $892.61 million, a PE ratio of -4.11 and a beta of 1.79. The firm's 50 day moving average price is $9.15 and its 200-day moving average price is $7.31. Anteris Technologies Global has a twelve month low of $3.17 and a twelve month high of $11.06. Analyst upgrades and downgrades. AVR has been the subject of a number of recent research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Barclays lifted their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an "overweight" rating in a research report on Friday, May 15th. Finally, Wall Street Zen raised Anteris Technologies Global from a "sell" rating to a "hold" rating in a research note on Saturday, May 16th. Four research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Anteris Technologies Global has a consensus rating of "Moderate Buy" and a consensus target price of $16.00. Insider transactions at Anteris Technologies Global. In other news, major shareholder L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10. Following the sale, the insider owned 5,439,000 shares in the company, valued at $44,055,900. This trade represents a 3.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold a total of 2,373,000 shares of company stock valued at $19,387,842 over the last three months. 4.50% of the stock is owned by company insiders. Institutional inflows and outflows. Several institutional investors have recently modified their holdings of AVR. ADAR1 Capital Management LLC increased its holdings in shares of Anteris Technologies Global by 526.9% in the 4th quarter. ADAR1 Capital Management LLC now owns 1,238,777 shares of the company's stock valued at $6,181,000 after acquiring an additional 1,041,162 shares during the last quarter. Millennium Management LLC lifted its holdings in Anteris Technologies Global by 21.7% in the 4th quarter. Millennium Management LLC now owns 85,646 shares of the company's stock valued at $427,000 after acquiring an additional 15,266 shares during the last quarter. Bridgeway Capital Management LLC acquired a new position in shares of Anteris Technologies Global in the 4th quarter worth $175,000. Price T Rowe Associates Inc. MD increased its position in shares of Anteris Technologies Global by 78.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 22,875 shares of the company's stock worth $115,000 after acquiring an additional 10,073 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of Anteris Technologies Global by 3.0% in the fourth quarter. Barclays PLC now owns 148,128 shares of the company's stock worth $739,000 after purchasing an additional 4,289 shares in the last quarter. About Anteris Technologies Global. Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Continue following MarketBeat Before you consider Anteris Technologies Global, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list. While Anteris Technologies Global currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you'll find 7 stocks that could play a major role in the next tech-driven market boom.

Perceptive Advisors LLC boosts holdings in Anteris Technologies Global Corp. $AVR. August 2, 2026 Key points. * Perceptive Advisors more than doubled its Anteris Technologies Global stake in the first quarter, adding 1.75 million shares to own approximately 3.52% of the company, valued at $19.0 million. * Anteris reported a quarterly loss of $0.28 per share and revenue of $490,000, both slightly below analyst expectations. The stock opened at $7.84, compared with a $2.99-$11.06 one-year trading range. * Analyst sentiment remains mixed but leans positive: Barclays raised its target to $18 and maintained an "overweight" rating, while the consensus rating is "Moderate Buy" with a $16 average price target; meanwhile, insiders sold significantly more shares than they bought recently. * MarketBeat previews the top five stocks to own by September 1st. Perceptive Advisors LLC boosted its holdings in shares of Anteris Technologies Global Corp. (NASDAQ:AVR - Free Report) by 104.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,425,476 shares of the company's stock after acquiring an additional 1,750,000 shares during the period. Perceptive Advisors LLC owned about 3.52% of Anteris Technologies Global worth $19,011,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds also recently modified their holdings of AVR. Russell Investments Group Ltd. increased its stake in shares of Anteris Technologies Global by 76.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company's stock worth $29,000 after purchasing an additional 2,841 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Anteris Technologies Global in the 1st quarter valued at approximately $32,000. BNP Paribas Financial Markets lifted its stake in Anteris Technologies Global by 83.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company's stock valued at $43,000 after buying an additional 4,302 shares in the last quarter. Bank of America Corp DE grew its holdings in Anteris Technologies Global by 35.7% during the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company's stock valued at $48,000 after buying an additional 2,798 shares during the last quarter. Finally, Duncan Williams Asset Management LLC acquired a new stake in Anteris Technologies Global during the 4th quarter valued at $54,000. Anteris Technologies Global stock performance. AVR stock opened at $7.84 on Friday. The company has a 50 day moving average price of $9.22 and a two-hundred day moving average price of $7.14. The stock has a market capitalization of $763.15 million, a P/E ratio of -3.52 and a beta of 1.65. Anteris Technologies Global Corp. has a one year low of $2.99 and a one year high of $11.06. Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.The business had revenue of $0.49 million for the quarter, compared to analysts' expectations of $0.77 million. During the same period in the prior year, the company earned ($0.61) EPS. Research analysts forecast that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current fiscal year. Insider buying and selling at Anteris Technologies Global. In related news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of the company's stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $8.20, for a total value of $4,580,790.60. Following the completion of the transaction, the insider directly owned 6,633,314 shares in the company, valued at approximately $54,393,174.80. This represents a 7.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Susan Elizabeth Knight bought 11,000 shares of Anteris Technologies Global stock in a transaction that occurred on Tuesday, June 2nd. The shares were acquired at an average price of $9.29 per share, for a total transaction of $102,190.00. Following the completion of the transaction, the director directly owned 11,000 shares of the company's stock, valued at $102,190. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders sold 1,178,686 shares of company stock valued at $9,613,446 over the last quarter. Insiders own 4.50% of the company's stock. Analyst Ratings changes. A number of research firms have recently weighed in on AVR. Wall Street Zen raised Anteris Technologies Global from a "sell" rating to a "hold" rating in a report on Saturday, May 16th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Finally, Barclays boosted their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an "overweight" rating in a research note on Friday, May 15th. Four equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Anteris Technologies Global currently has an average rating of "Moderate Buy" and an average price target of $16.00. Discover more EV Market Report Stock Screener Tool Anteris Technologies Global profile. Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN. Want to see what other hedge funds are holding AVR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anteris Technologies Global Corp. (NASDAQ:AVR - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Anteris Technologies Global, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list. While Anteris Technologies Global currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain - combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Anteris Technologies Global Corp., a structural heart company, has appointed Susan Knight and Stephen Denaro to its Board of Directors as it advances its DurAVR transcatheter heart valve through global pivotal trials. Knight, former Board Chair of Surmodics and ex-CFO of MTS Systems Corporation, will serve as a Class I Director until 2028 and join the Audit and Risk Committee. Denaro returns as a Class II Director with a term expiring in 2026. The appointments strengthen governance as Anteris prepares for anticipated US and European regulatory approval of its DurAVR device, which treats aortic stenosis. The company's ADAPT tissue technology has been used in over 55,000 patients worldwide over the past decade.